Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 19301-19350 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT02600910
Natural History of Shoulder Pathology in Manual Wheelchair Users
N/A
Active, not recruiting
75 participants
Started: Nov 30, 2015 · Completed: Aug 31, 2026
4 conditions
3 sponsors
2 locations
NCT02474368
Study Evaluating a Stereotactic Boost/Treatment for Recurrent or Metastatic Cancer of the Head and Neck
PHASE1
Active, not recruiting
21 participants
Started: Nov 30, 2015 · Completed: Jun 30, 2026
3 conditions
1 sponsor
1 location
NCT03771001
5Minutes4Myself: A Wellness Program for Caregivers
NA
Active, not recruiting
25 participants
Started: Nov 30, 2015 · Completed: Dec 31, 2025
3 conditions
1 sponsor
1 location
NCT02610582
Safety and Efficacy of rAAV.hCNGA3 Gene Therapy in Patients With CNGA3-linked Achromatopsia
PHASE1/PHASE2
Active, not recruiting
13 participants
Started: Nov 30, 2015 · Completed: Jun 30, 2027
1 condition
3 sponsors
1 location
NCT02588690
Beauty from Within Community Screening Project
N/A
Active, not recruiting
400 participants
Started: Nov 30, 2015 · Completed: Nov 30, 2030
1 condition
1 sponsor
1 location
NCT02527044
Impact of Preoperative FFR on Arterial Bypass Graft Functionality
NA
Active, not recruiting
120 participants
Started: Nov 30, 2015 · Completed: Nov 30, 2028
1 condition
1 sponsor
2 locations
NCT03456622
BC Study of G7 Cup and Compatible Femoral Stems
N/A
Active, not recruiting
230 participants
Started: Nov 30, 2015 · Completed: Dec 31, 2030
4 conditions
1 sponsor
1 location
NCT02602457
Exercise Training in Patients With Atrial Fibrillation (OPPORTUNITY Study)
NA
Active, not recruiting
94 participants
Started: Nov 30, 2015 · Completed: Oct 31, 2030
1 condition
1 sponsor
1 location
NCT02914366
Ambroxol as a Treatment for Parkinson's Disease Dementia
PHASE2
Active, not recruiting
55 participants
Started: Nov 30, 2015 · Completed: Dec 31, 2025
1 condition
4 sponsors
1 location
NCT02735291
Study Evaluating the Efficacy and Safety With CAR-T for Recurrent or Refractory Acute Non T Lymphocyte Leukemia
NA
Active, not recruiting
72 participants
Started: Nov 30, 2015 · Completed: Dec 31, 2025
1 condition
2 sponsors
2 locations
NCT02601495
Latent Structure of Multi-level Assessments and Predictors of Outcomes for Women in Recovery
N/A
Active, not recruiting
100 participants
Started: Nov 30, 2015 · Completed: Nov 30, 2028
5 conditions
4 sponsors
0 locations
NCT02489318
A Study of Apalutamide (JNJ-56021927, ARN-509) Plus Androgen Deprivation Therapy (ADT) Versus ADT in Participants With mHSPC
PHASE3
Active, not recruiting
1,052 participants
Started: Nov 27, 2015 · Completed: Dec 31, 2027
1 condition
1 sponsor
222 locations
NCT03191955
Muscle Wasting in Cancer (MWIC)
N/A
Active, not recruiting
120 participants
Started: Nov 26, 2015 · Completed: Aug 1, 2025
1 condition
3 sponsors
1 location
NCT02615275
Bioelectrical Impedance Analysis in Estimating Body Composition in Patients With Stage I-IV Head and Neck Cancer Undergoing Radiation Therapy
NA
Active, not recruiting
50 participants
Started: Nov 24, 2015 · Completed: Nov 30, 2026
1 condition
2 sponsors
1 location
NCT02612662
A Study to Assess the Safety and Tolerability of Single Doses of AZD4076 in Healthy Male Subjects
PHASE1
Active, not recruiting
40 participants
Started: Nov 24, 2015 · Completed: Aug 29, 2025
1 condition
1 sponsor
1 location
NCT01905046
Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast Cancer
PHASE3
Active, not recruiting
86 participants
Started: Nov 23, 2015 · Completed: Nov 30, 2025
5 conditions
2 sponsors
27 locations
NCT02337985
Gene Therapy and Combination Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin Lymphoma
PHASE1
Active, not recruiting
10 participants
Started: Nov 20, 2015 · Completed: Oct 2, 2025
6 conditions
2 sponsors
1 location
NCT04439331
Testing VS-6063 (Defactinib) as a Potential Targeted Treatment in Cancers With NF2 Genetic Changes (MATCH-Subprotocol U)
PHASE2
Active, not recruiting
35 participants
Started: Nov 19, 2015 · Completed: Dec 31, 2025
6 conditions
1 sponsor
1 location
NCT02568267
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)
PHASE2
Active, not recruiting
534 participants
Started: Nov 19, 2015 · Completed: Dec 31, 2025
16 conditions
1 sponsor
128 locations
NCT02531516
An Efficacy and Safety Study of JNJ-56021927 (Apalutamide) in High-risk Prostate Cancer Subjects Receiving Primary Radiation Therapy: ATLAS
PHASE3
Active, not recruiting
1,503 participants
Started: Nov 19, 2015 · Completed: Dec 29, 2028
1 condition
1 sponsor
262 locations
NCT03396224
Avenir® Cemented Hip Stem - PMCF
N/A
Active, not recruiting
100 participants
Started: Nov 18, 2015 · Completed: Nov 30, 2030
7 conditions
1 sponsor
3 locations
NCT04033757
A Population-based Cohort of Osteoarthritis: the Xiangya Osteoarthritis Study
N/A
Active, not recruiting
4,080 participants
Started: Nov 17, 2015 · Completed: Dec 31, 2031
1 condition
3 sponsors
1 location
NCT02293954
Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer
NA
Active, not recruiting
20 participants
Started: Nov 11, 2015 · Completed: Sep 11, 2025
12 conditions
2 sponsors
1 location
NCT02611427
Increasing Long-Term Physical Activity After Lumbar Spine Surgery
NA
Active, not recruiting
260 participants
Started: Nov 11, 2015 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT02605486
Palbociclib in Combination With Bicalutamide for the Treatment of AR(+) Metastatic Breast Cancer (MBC)
PHASE1/PHASE2
Active, not recruiting
46 participants
Started: Nov 11, 2015 · Completed: Nov 30, 2026
1 condition
2 sponsors
5 locations
NCT02656550
Uterine Transplantation and Pregnancy Induction in Women Affected by Absolute Uterine Infertility
NA
Active, not recruiting
20 participants
Started: Nov 11, 2015 · Completed: Jan 31, 2026
1 condition
1 sponsor
1 location
NCT02506153
Physician/Patient Choice of Either High-Dose Recombinant Interferon Alfa-2B or Ipilimumab, Versus Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery
PHASE3
Active, not recruiting
1,301 participants
Started: Nov 10, 2015 · Completed: Jan 23, 2026
9 conditions
1 sponsor
578 locations
NCT02677974
On-X Aortic Prosthetic Heart Valve Low Dose Warfarin Post Approval Clinical Registry Study
N/A
Active, not recruiting
510 participants
Started: Nov 10, 2015 · Completed: Aug 31, 2027
1 condition
2 sponsors
23 locations
NCT02276443
Molecular Testing and Imaging in Improving Response in Patients With Stage I-III Triple-Negative Breast Cancer Receiving Chemotherapy MDACC Breast Moonshot Initiative
NA
Active, not recruiting
798 participants
Started: Nov 9, 2015 · Completed: Nov 30, 2026
12 conditions
2 sponsors
5 locations
NCT02504372
Study of Pembrolizumab (MK-3475) vs Placebo for Participants With Non-small Cell Lung Cancer After Resection With or Without Standard Adjuvant Therapy (MK-3475-091/KEYNOTE-091)
PHASE3
Active, not recruiting
1,177 participants
Started: Nov 6, 2015 · Completed: Jan 21, 2026
1 condition
3 sponsors
0 locations
NCT02506933
Multi-antigen CMV-MVA Triplex Vaccine in Reducing CMV Complications in Patients Previously Infected With CMV and Undergoing Donor Hematopoietic Cell Transplant
PHASE2
Active, not recruiting
102 participants
Started: Nov 5, 2015 · Completed: Jun 9, 2026
13 conditions
3 sponsors
3 locations
NCT02542293
Study of Durvalumab With Tremelimumab Versus SoC as 1st Line Therapy in Metastatic Non Small-Cell Lung Cancer (NSCLC) (NEPTUNE)
PHASE3
Active, not recruiting
953 participants
Started: Nov 3, 2015 · Completed: Dec 31, 2025
1 condition
1 sponsor
210 locations
NCT03620032
Study of Re-irradiation at Relapse Versus RT and Multiple Elective rt Courses
PHASE2
Active, not recruiting
54 participants
Started: Nov 2, 2015 · Completed: Nov 2, 2024
1 condition
5 sponsors
1 location
NCT02516241
Study of MEDI4736 (Durvalumab) With or Without Tremelimumab Versus Standard of Care Chemotherapy in Urothelial Cancer
PHASE3
Active, not recruiting
1,126 participants
Started: Nov 2, 2015 · Completed: Dec 31, 2025
1 condition
1 sponsor
222 locations
NCT02547987
Neoadjuvant Carboplatin and Docetaxel in Triple Negative Breast Cancer
PHASE2
Active, not recruiting
25 participants
Started: Nov 1, 2015 · Completed: Sep 30, 2025
1 condition
1 sponsor
3 locations
NCT03343236
Nutrition and Inflammation in Patients with Head and Neck Cancer
N/A
Active, not recruiting
522 participants
Started: Nov 1, 2015 · Completed: Dec 31, 2027
4 conditions
4 sponsors
1 location
NCT02736669
CARE Trial: Comparing Different Levels of Calorie Reduction for Weight Loss
NA
Active, not recruiting
223 participants
Started: Oct 31, 2015 · Completed: Dec 31, 2025
2 conditions
2 sponsors
1 location
NCT03052114
Electrical Impedance Tomography of Stroke and Brain Injury
N/A
Active, not recruiting
150 participants
Started: Oct 31, 2015 · Completed: Dec 31, 2027
2 conditions
2 sponsors
1 location
NCT02591563
Evaluate Pathogens and Immunity to Acute Otitis Media in Healthy Children.
N/A
Active, not recruiting
1,320 participants
Started: Oct 31, 2015 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT02573532
Incidence and Outcome of Perioperative Myocardial Injury After Non-cardiac Surgery
N/A
Active, not recruiting
16,204 participants
Started: Oct 31, 2015 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT02633111
DNA Sequencing-Based Monitoring of Minimal Residual Disease to Predict Clinical Relapse in Aggressive B-cell Non-Hodgkin Lymphomas
N/A
Active, not recruiting
501 participants
Started: Oct 31, 2015 · Completed: Oct 31, 2025
2 conditions
5 sponsors
12 locations
NCT02592083
Neoadjuvant Response-guided Treatment of Slowly Proliferating Hormone Receptor Positive Tumors
PHASE2
Active, not recruiting
10 participants
Started: Oct 31, 2015 · Completed: Feb 28, 2029
2 conditions
1 sponsor
1 location
NCT02649959
An Open Label Study of CM-AT for the Treatment of Children With Autism
PHASE3
Active, not recruiting
405 participants
Started: Oct 31, 2015 · Completed: Jan 31, 2028
1 condition
1 sponsor
31 locations
NCT02194842
Phase III Radium 223 mCRPC-PEACE III
PHASE3
Active, not recruiting
446 participants
Started: Oct 31, 2015 · Completed: Dec 31, 2028
1 condition
7 sponsors
64 locations
NCT02579408
Quantifying Steatosis in Liver Transplant Donors
N/A
Active, not recruiting
100 participants
Started: Oct 31, 2015 · Completed: May 31, 2026
2 conditions
1 sponsor
1 location
NCT02353819
Stereotactic Ablative Radiotherapy (SABR) of Pelvis and Prostate Targets For High Risk Prostate Cancer
PHASE1
Active, not recruiting
60 participants
Started: Oct 31, 2015 · Completed: Dec 31, 2030
1 condition
2 sponsors
1 location
NCT02520713
The iCat2, GAIN (Genomic Assessment Informs Novel Therapy) Consortium Study
N/A
Active, not recruiting
825 participants
Started: Oct 31, 2015 · Completed: Oct 31, 2026
1 condition
1 sponsor
12 locations
NCT02566200
French Registry of Acute ST-elevation or Non-ST-elevation Myocardial Infarction 2015
N/A
Active, not recruiting
5,000 participants
Started: Oct 31, 2015 · Completed: Oct 31, 2027
1 condition
2 sponsors
1 location
NCT02600208
Peripheral Blood Stem Cell Transplantation for Hematologic Malignancies with Alpha Beta TCell and B Cell Depletion Using the CliniMACS Device
PHASE2/PHASE3
Active, not recruiting
60 participants
Started: Oct 31, 2015 · Completed: Dec 31, 2026
1 condition
2 sponsors
1 location
NCT02215265
Post-operative Adjuvant Treatment for HPV-positive Tumours (PATHOS)
PHASE3
Active, not recruiting
1,269 participants
Started: Oct 31, 2015 · Completed: Apr 30, 2028
1 condition
6 sponsors
57 locations
Previous
1
More pages
384
385
386
387
388
389
390
More pages
431
Next